On 2 Dec 2022, our outstanding presenters received big achievements by winning amazing awards at the 10th HTAsiaLink Annual Conference 2022 which virtually held on 30 November – 2 December 2022. The winners are as listed below:Best Oral PresentationsTrack: Economic EvaluationSecond Prize: Chittawan

https://www.youtube.com/watch?v=QnmnyZ14A4wIn health systems, although there are many stakeholders with different interests (healthcare practitioners, policymakers, industry, patients and the public), many share the value of better health for all. However, when a decision needs to be made, it is not

How do decision-makers in Thailand decide whether a new or improved vaccine should be added to the Expanded Program on Immunization (EPI)?What is the vaccine prioritization and selection processes in Thailand?How can the product preferences of low and middle-income countries (LMICS) be better commun

(Reuters) – The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor and wealthy countries alike set up pilot projects to better understand the benefits.The United Nations agency made its sugg

PrePex, a bloodless circumcision device for adults, will be tested in at least nine African countries in the next year, according to the backers of the tests.The device, above, was approved by the Food and Drug Administration in January, and World Health Organization approval is expected soon. No su

People with highly stressful jobs but little real control over decision making are running a 23% increased risk of a heart attack, according to authoritative research.Many people in today’s world, where the pace of life is fast and money is tight, may consider themselves stressed at work, but the de

Achieving universal health coverage (UHC) requires policy initiatives supported by long-term system reform and an accountable governance structure that can sustainably deliver all three dimensions of UHC, population coverage, breadth of benefits package, and degree of financial coverag

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q

Abstract Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a pharmaceutical reimbursement list in Thailand. There have also been no economic evaluation studies of CHB drug treatments conducted in Thailand yet. I

SUMMARY POINTS •  End stage renal disease (ESRD) is a life-threatening condition that results in most patients requiring a lifetime of high cost renal dialysis •  Governments have grappled with the political, economic, and ethical challenges of providing treatment with their available budgets •